Advertising Botox & Fillers: Aesthetics Ad Policy Explained

The most common aesthetics ad disapproval traces to one overlooked fact: Botox is a brand-name prescription drug. So are Dysport, Xeomin, and most dermal fillers. Med spas market them like beauty services — platforms police them like pharmaceuticals. Both are being internally consistent; only one controls your ad account.

The three rule sets that hit aesthetics ads

1. Prescription drug rules. Non-pharma advertisers face restrictions on prescription brand names in ad copy on Google and Meta. Enforcement is uneven — plenty of "Botox" ads slip through — but uneven enforcement is a trap: campaigns built on it collapse the day review catches up, usually mid-flight on your best performers. Category language ("wrinkle-relaxing injections," "neurotoxin treatments," "lip filler") is durable; brand names on landing pages (where policy pressure is lower) capture branded search intent.

2. Personal-attribute and body-image rules. Meta prohibits ads implying knowledge of personal attributes ("unhappy with your wrinkles?") and restricts imagery that promotes negative self-perception. Extreme-closeup "flaw" imagery and shame-based angles get flagged — and even when they don't, they attract the wrong reactions. Aspiration outperforms insecurity in both review rates and results.

3. Before/after restrictions. The aesthetics workhorse is heavily policed, especially on Meta. It deserves its own playbook — we wrote one — but the summary: unrealistic-outcome framing and zoomed body/face transformations are the flag magnets.

Offers and pricing: the quieter risk

Aggressive discount mechanics ("$99 Botox!") create two problems. Platforms scrutinize health services marketed like flash sales, and several state medical boards restrict discount advertising for medical procedures. Structure value around consultations, new-patient experiences, or memberships rather than per-unit pricing wars — better for review, better for margins, better for the clientele you attract.

What a durable aesthetics campaign looks like

• Category-language ads describing treatments and the practice, brand names reserved for landing pages and organic content
• Provider-forward creative — the injector explaining a treatment converts trust into bookings and sails through review (the full med spa system is here)
• Aspirational imagery over flaw-focused imagery
• Consultation-centered offers rather than unit pricing
• Landing pages audited to ad standards — claims, testimonials, and image captions included

None of this dulls performance. In our experience it improves it: the same constraints that satisfy policy review also signal legitimacy to patients choosing who gets to put a needle in their face. Compliance and conversion point the same direction in aesthetics more than almost any category.

---

Neural Stack runs compliant paid campaigns for med spas and aesthetics practices — injectables included. Book a free consultation.